Omics-based identification of an NRF2-related auranofin resistance signature in cancer: Insights into drug repurposing
- DOI
- 10.1016/j.compbiomed.2022.106347
- Published
- 2023-01
- Container
- Computers in Biology and Medicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.compbiomed.2022.106347,
title = {Omics-based identification of an NRF2-related auranofin resistance signature in cancer: Insights into drug repurposing},
author = {Marcelo Falchetti and Marina Delgobo and Helena Zancanaro and Karoline Almeida and Raquel Nascimento das Neves and Barbara dos Santos and Natália Marcéli Stefanes and Alexander Bishop and Maria Cláudia Santos-Silva and Alfeu Zanotto-Filho},
year = {2023},
journal = {Computers in Biology and Medicine},
doi = {10.1016/j.compbiomed.2022.106347},
url = {https://doi.org/10.1016/j.compbiomed.2022.106347}
}RIS
TY - JOUR TI - Omics-based identification of an NRF2-related auranofin resistance signature in cancer: Insights into drug repurposing AU - Marcelo Falchetti AU - Marina Delgobo AU - Helena Zancanaro AU - Karoline Almeida AU - Raquel Nascimento das Neves AU - Barbara dos Santos AU - Natália Marcéli Stefanes AU - Alexander Bishop AU - Maria Cláudia Santos-Silva AU - Alfeu Zanotto-Filho PY - 2023 JO - Computers in Biology and Medicine DO - 10.1016/j.compbiomed.2022.106347 UR - https://doi.org/10.1016/j.compbiomed.2022.106347 ER -
APA
Falchetti, M., Delgobo, M., Zancanaro, H., Almeida, K., Neves, R. N. D., Santos, B. D., Stefanes, N. M., Bishop, A., Santos-Silva, M. C., & Zanotto-Filho, A. (2023). Omics-based identification of an NRF2-related auranofin resistance signature in cancer: Insights into drug repurposing. Computers in Biology and Medicine. https://doi.org/10.1016/j.compbiomed.2022.106347
Source records
- crossref · retrieved 2026-09-26T15:57:16.424Z